Renal Cancer - Results from #3680

Association of Partial versus Radical Nephrectomy with Subsequent Hypertension Risk Following Renal Tumor Resection. April 5, 2019

The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: A study based on TCGA and Cmap datasets. April 5, 2019

The Changing Landscape of Management of Metastatic Renal Cell Carcinoma: Current Treatment Options and Future Directions. April 4, 2019

OUTCOMES OF PARTIAL AND RADICAL NEPHRECTOMY IN OCTOGENARIANS - A MULTICENTER INTERNATIONAL STUDY (RESURGE). April 4, 2019

Comprehensive Analysis of Driver Genes in Personal Genomes of Clear Cell Renal Cell Carcinoma. April 4, 2019

Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study. April 3, 2019

Chemoimmunotherapy in Advanced Renal Cell Carcinoma: A Case Report of a Long-Term Survivor Adjunctly Treated with Viscum album Extracts. April 3, 2019

A comparison of outcomes for standard and multiplex partial nephrectomy in a solitary kidney: The National Cancer Institute experience. April 3, 2019

The adjuvant treatment of kidney cancer: a multidisciplinary outlook. April 2, 2019

Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIMSM registry. April 2, 2019

Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma - a retrospective study using TCGA database. April 2, 2019

Survival outcomes associated with different sunitinib dosing regimens in metastatic renal cell carcinoma. April 1, 2019

Impact of routine imaging in the diagnosis of recurrence for patients with localized and locally advanced renal tumor treated with nephrectomy. April 1, 2019

Nephrometry score correlated with tumor proliferative activity inT1 clear cell renal cell carcinoma. April 1, 2019

Clonal architectures predict clinical outcome in clear cell renal cell carcinoma. March 29, 2019

Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients. March 29, 2019

Elevated plasma interleukin 6 predicts poor response in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. March 29, 2019

Comparative STAT3-Regulated Gene Expression Profile in Renal Cell Carcinoma Subtypes. March 28, 2019

IL-8 and CXCR1 expression is associated with cancer stem cell-like properties of clear cell renal cancer. March 28, 2019

Surgical treatment for renal masses in the elderly: analysis of oncological, surgical and functional outcomes. March 28, 2019

Page 185 of 456